A specific variant known as CYP2C19 synthesizes molecules from arachidonic acids like epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acid, which help to maintain the health of blood vessels and the heart and have been found to predict CAD risk. Here, CYP2C19 is linked to coronary artery disorder.